Joint Formulary & PAD

Levonorgestrel - Menorrhagia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Intrauterine device (progestogen only)
Associated Icons :
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Levonorgestrel
Indication :
Menorrhagia
Group Name :
Keywords :
IUD, intrauterine devices,
Brand Names Include :
Benilexa, Levosert, Mirena
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agreed the following traffic light status for treating menorrhagia associated with fibroids:

 GREEN traffic light status

  • Tranexamic acid tablets
  • Norethisterone
  • Combined Hormonal Contraception
  • Levonorgestrel intrauterine system (LNG-IUS) - Benilexa, levosert & Mirena

RED traffic light status

GnRH/LHRH analogues

  • Triptorelin (Decapeptyl SR® 3.75mg)
  • Leuprorelin (Prostap SR DCS®) 3.75mg
  • Gosereline acetate (Zoladex® 3.6mg)

Other Indications

Below are listed other indications that Levonorgestrel is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Menorrhagia.